RDY Stock Recent News

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Dr Reddy's Laboratories Ltd (NYSE:RDY ) Q4 2023 Earnings Conference Call May 10, 2023 10:00 AM ET Company Participants Richa Periwal - IR Gunupati Prasad - Co-Chairman Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Balaji Prasad - Barclays Bank Surya Patra - PhillipCapital Damayanti Kerai - HSBC Cyndrella Carvalho - JM Financial Ankush Mahajan - Axis Securities Nitin Agarwal - DAM Capital Advisors Madhav Marda - FI Industries Tushar Manudhane - Motilal Oswal Financial Services Kunal Dhamesha - Macquarie Research Neha Manpuria - Bank of America Merrill Lynch Ashish Chopra - IIFL Asset Management Prakash Agarwal - Axis Capital Limited Operator Ladies and gentlemen, good day, and welcome to the Dr. Reddy's Q4 FY '23 Earnings Conference Call. [Operator Instructions].

The Profitable Predictable Margin Expanders screener on GuruFocus has been a helpful one for me when searching for quality stocks that show solid growth. It does what the name suggests - it sorts through the thousands of stocks in the GuruFocus database and selects those that are currently profitable, have a business predictability ranking of at least 3 out of 5 stars and have expanding operating margins.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Growth in key emerging markets, including India and Russian footprint. Positive Q3 FY23 results with top–bottom line growth. Solid FCF conversion and returns on capital.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Dr. Reddy's (RDY) beat earnings and revenues in the fiscal third quarter, driven by growth in the United States and Russian markets.

Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q3 2023 Earnings Conference Call January 25, 2023 8:30 AM ET Company Participants Richa Periwal - IR Parag Agarwal - CFO Erez Israeli - CEO Amit Agarwal - Head, IR & Director, Finance Conference Call Participants Kunal Dhamesha - Macquarie Group Damayanti Kerai - HSBC Surya Patra - Philip Capital Prakash Agarwal - Axis Capital Sameer Baisiwala - Morgan Stanley Prashant Nair - Ambit Capital Saion Mukherjee - Nomura Rahul Singh - IIFL Securities Shyam Srinivasan - Goldman Sachs Operator Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q3 FY 2023 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

STNE, JD, VSH, MOMO and RDY have been added to the Zacks Rank #1 (Strong Buy) List on January 10 , 2023.

The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.